If your clinical workflow has been interrupted by the latest “miracle” tool promising to automate your diagnosis and treatment plans, you are not alone. Millions of physicians across the country are feeling the same pressure to adopt artificial intelligence in their daily practice. However, there is a significant problem holding us back. Many of these tools act like a black box, giving us answers without showing the work or the evidence behind them. This can be incredibly frustrating and dangerous in a high-stakes environment where a single error can lead to patient harm. Did you know that trust in these systems is the number one barrier to their widespread adoption in hospitals? It is because we, as clinicians, are trained to rely on primary sources such as the New England Journal of Medicine or the Lancet, not on a generative model that might be guessing. In this blog post, we will discuss the shift from black box models to the glass box approach of evidence-based clinical AI, specifically looking at how companies like OpenEvidence are winning the trust of academic medicine.
What is the “Black Box” Problem in Clinical AI?
The primary concern many physicians have with early generative AI models is the risk of hallucination. When a model provides a clinical recommendation without a direct link to a peer-reviewed source, it is essentially asking the doctor to take a leap of faith. However, in medicine, we do not take leaps of faith. We rely on data. Tun HM et al, *Journal of Medical Internet Research* 2025, highlights that trust in artificial intelligence systems among health care workers is highly dependent on transparency and the ability to verify claims. When a system provides an answer that “looks” right but lacks a foundation in clinical reality, it creates a dangerous situation.
Moreover, the “black box” nature of these models means that even the developers often cannot explain why the AI reached a specific conclusion. This lack of interpretability is a major hurdle for clinical decision support. If you’re wondering why this matters so much, think about a complex oncology case. A recommendation for a specific chemotherapy regimen must be backed by the latest trial data. Without that evidence, the recommendation is essentially useless to a specialist.
Evidence-based clinical AI aims to solve this by moving toward a “glass box” model. Instead of just generating text, these systems are designed to retrieve information directly from verified medical literature. This change is essential to ensuring that the technology helps rather than hinders the clinical process. Ouanes K et al, *Journal of Medical Systems* 2024, found that the effectiveness of AI in clinical decision support depends heavily on how well it integrates with existing care delivery standards. When the AI operates in a vacuum, the risk of error increases significantly.
OpenEvidence and the Move Toward Glass Box Transparency
OpenEvidence is currently making a major push to convince hospitals that they are not like the “monsters” of generative AI. According to recent reports, the company is pitching a transparency-first model that focuses on evidence-based retrieval rather than pure generation. This is a strategic move to distance the platform from high-profile AI hallucination errors that have made headlines over the last year. By focusing on a “glass box” approach, they are trying to prove that their tool can be a verified clinical decision support system rather than a black box that guesses.
The company is positioning itself as a partner to academic medicine. This involves integrating their platform into hospital EHR systems as a tool that clinicians can actually trust. Undoubtedly, the shift toward this model is a response to the growing demand from physicians for tools that cite their sources. If a clinician can see exactly where a piece of information came from, such as a specific PubMed ID or a CDC guideline, the trust barrier begins to dissolve.
Yes, this is a significant change in how AI companies approach the healthcare market. In the past, the focus was on how “smart” the AI could be. Now, the focus is on how “honest” and “transparent” it is. This is essential for tools that are intended to assist in high-stakes clinical decisions. OpenEvidence is betting that hospitals will prefer a tool that says “I don’t know” or “the evidence is inconclusive” over one that provides a confident but false answer.
How Evidence-Based Retrieval Differs from Generative Guessing
It is important to understand the technical difference between standard generative models and evidence-based clinical AI. Most large language models work by predicting the next most likely word in a sentence. While this works well for writing emails or creative stories, it is not a safe way to handle medical data. Retrieval-augmented generation (RAG) is the technical term for what companies like OpenEvidence are doing. This involves the AI searching a curated database of medical literature first, then using that data to construct an answer.
Ozmen BB et al, *Journal of Plastic, Reconstructive & Aesthetic Surgery* 2025, discuss how implementing retrieval-augmented generation models can enhance clinical decision support. In their research, they found that these models are far more reliable in specialized fields such as plastic surgery because they are grounded in actual evidence. They are not guessing. They are summarizing existing knowledge.
Simply put, a generative model is like a student who has memorized a lot of books but doesn’t have them with him during a test. He might remember the facts correctly, or he might misremember and make something up that sounds plausible. An evidence-based clinical AI is like a student who has all those books open on his desk during the test. He can point to the exact page and paragraph that supports his answer. That is the difference between a black box and a glass box.
The Essential Role of Peer-Reviewed Citations in Physician Trust
There is no exaggeration in saying that citations are the currency of medical trust. Without them, any clinical claim is just an opinion. Tun HM et al, *Journal of Medical Internet Research* 2025, conducted a systematic review that confirmed health care workers are much more likely to trust a system that provides clear evidence for its recommendations. The study pointed out that trust is not a binary state. It is built over time through consistent and verifiable accuracy.
Besides this, the ability to delabel or verify information is a multidisciplinary opportunity. Staicu ML et al, *The Journal of Allergy and Clinical Immunology: In Practice* 2020, highlight how evidence-based systems can help in areas such as penicillin allergy delabeling. When clinicians have access to clear, evidence-based guidelines and support, they can make better decisions that improve patient outcomes. If an AI tool can point to the specific guideline from the American College of Chest Physicians, as discussed by Holbrook A et al, *Chest* 2012, it becomes a much more powerful ally in the clinic.
What’s more, the use of primary sources helps to prevent the “echo chamber” effect of AI training. If a model is trained on another model’s output, errors can be amplified. By going back to the original research every time, evidence-based clinical AI ensures that it is providing the most accurate and up-to-date information available. This is an essential part of maintaining the high standards of academic medicine.
Why Retrieval-Augmented Generation is the Standard for Academic Medicine
If you’re wondering why academic institutions are leading the charge for these tools, it is because their reputation is built on evidence. A teaching hospital cannot afford to use a tool that might provide a hallucinated citation. This is why the shift toward RAG models is so significant. Ozmen BB et al, *Journal of Plastic, Reconstructive & Aesthetic Surgery* 2025, emphasize that these models are particularly useful for enhancing decision support because they provide a bridge between raw data and clinical application.
Moreover, these systems can help bridge the gap between different specialties. A surgeon might need quick information on a medication interaction that falls under internal medicine. An evidence-based AI can provide that information along with the primary source, allowing the surgeon to verify the fact in seconds. This speed and accuracy are what make these tools so valuable in a fast-paced hospital environment.
Integrating AI into Hospital EHR Workflows
For any clinical tool to be successful, it must be integrated into the workflow. Nobody wants to log into a separate website to check a fact. This is why OpenEvidence and others are focusing on EHR integration. Akay EMZ et al, *Stroke* 2023, looked at artificial intelligence for clinical decision support in acute ischemic stroke and found that the most effective systems were those that could be used at the point of care. If the AI is built into the chart, the clinician is more likely to use it.
However, integration is not just about the software. It is also about the clinical culture. Lin X et al, *Journal of Medical Internet Research* 2024, studied AI-augmented systems for pregnancy care and found that the human element is just as important as the technology. Clinicians need to feel that the tool is there to support them, not to replace their judgment. This is where the glass box model really shines. Because it provides citations, it respects the physician’s expertise and autonomy.
Rest assured, the goal of these integrations is not to add more alerts to an already crowded screen. Graafsma J et al, *Journal of the American Medical Informatics Association* 2024, performed a scoping review on how AI can optimize medication alerts. They found that AI can actually reduce alert fatigue by filtering out irrelevant warnings and providing more context-aware support. By using evidence-based clinical AI, hospitals can make their EHR systems smarter and less intrusive.
Addressing the Problem of Alert Fatigue
We all know the frustration of clicking through a dozen irrelevant alerts to get to the one that actually matters. This alert fatigue is a major cause of burnout and medical error. Graafsma J et al, *Journal of the American Medical Informatics Association* 2024, suggest that AI can help solve this by being more selective about when it interrupts a clinician. If the AI knows the evidence-based guidelines for a specific patient, it can only trigger an alert when a real deviation from the standard of care occurs.
This type of intelligent filtering requires a deep understanding of the medical literature. It is not something a simple rule-based system can do easily. By using evidence-based clinical AI, hospitals can ensure that their alerts are based on the latest research, which makes them much more credible to the physicians receiving them. In that case, you can rest assured that the system is working with you, not against you.
Clinical Decision Support in Specialized Medicine
Specialized fields have unique needs when it comes to evidence-based clinical AI. In oncology, for example, the pace of research is incredibly fast. Wang L et al, *International Journal of Medical Sciences* 2023, discuss how AI can help oncologists stay up to date with the latest clinical trials and drug approvals. Because oncology is so data-intensive, a tool that can quickly retrieve and summarize primary evidence is a huge asset.
Similarly, in pediatrics, the requirements for drug dosing and treatment can be very different from adult medicine. Ramgopal S et al, *Pediatric Research* 2023, highlight the role of AI-based clinical decision support in pediatrics. They point out that these systems must be specifically calibrated for the pediatric population and backed by relevant evidence. An AI that treats a child like a “small adult” is dangerous, which is why retrieval-based models are essential in this field.
Even in dentistry, the role of AI is growing. Mallineni SK et al, *Bioengineering* 2024, provide a descriptive review of AI in dentistry. They note that evidence-based systems can assist in everything from radiographic interpretation to treatment planning. In every specialty, the theme is the same. The AI must be grounded in the specific literature of that field to be useful and trusted.
Precision Medicine and AI Support
The ultimate goal for many of these tools is to support precision medicine. This involves tailoring treatment to the individual patient based on their genetics, lifestyle, and environment. Wang L et al, *International Journal of Medical Sciences* 2023, note that AI is particularly good at analyzing the complex datasets required for precision oncology. When this analysis is combined with an evidence-based approach, it allows for a level of personalization that was previously impossible.
However, this level of precision also requires a high degree of transparency. If an AI suggests an unconventional treatment for a specific patient, the oncologist needs to see the primary data that supports that suggestion. This is why the move toward glass box AI is not just a preference. It is a clinical necessity for the future of precision medicine.
Addressing the Risks of AI in Pharmacy and Nursing
The impact of evidence-based clinical AI extends beyond just physicians. Pharmacy practice is also being transformed. Chalasani SH et al, *Exploratory Research in Clinical and Social Pharmacy* 2023, conducted a literature review showing how AI can assist pharmacists in identifying medication errors and optimizing therapy. In a pharmacy setting, the risk of a “hallucinated” drug interaction is a nightmare scenario. This is why retrieval-based models are so important for pharmacists.
Nursing education and practice are also seeing a shift. El Arab RA et al, *Journal of Medical Internet Research* 2025, and Rony MKK et al, *Nursing Inquiry* 2025, both provide umbrella reviews on the role of AI in nursing. They found that while AI has great potential to support nursing care, it must be implemented carefully to maintain the quality of patient interaction. For a nurse at the bedside, a tool that provides quick, evidence-based answers to clinical questions can be an essential resource.
Undoubtedly, the goal is to create a multidisciplinary environment where all members of the care team are supported by the same high-quality evidence. Whether it is a pharmacist checking a complex drug interaction or a nurse assessing a wound, having access to an evidence-based clinical AI can improve the safety and efficiency of the entire hospital.
Limitations and Counter-Evidence: When AI Decision Support Fails
While the promise of evidence-based clinical AI is great, we must be honest about its limitations. No system is perfect. Ouanes K et al, *Journal of Medical Systems* 2024, point out that even when AI systems are effective, they can sometimes lead to an over-reliance on the technology. This is known as automation bias, where a clinician might stop questioning the tool’s recommendations. If the AI is wrong, and the doctor doesn’t catch it, the patient suffers.
Furthermore, the quality of the AI’s output is only as good as the underlying literature. If the medical studies themselves are flawed or biased, the AI will simply mirror those flaws. This is a significant concern in medical research, where many studies are small or poorly designed. Clinicians must always remember that the AI is a support tool, not a replacement for their own clinical judgment and critical thinking.
There is also the issue of implementation costs. Building and maintaining an evidence-based clinical AI system that is integrated into the EHR is incredibly expensive. Not all hospitals have the resources to implement these tools effectively. This could lead to a “digital divide” where academic medical centers have access to advanced AI support while smaller community hospitals are left behind.
Addressing False Positives and Alert Fatigue
Another major limitation is the issue of false positives. Even an evidence-based system can trigger too many alerts if the thresholds are set too low. This leads back to the problem of alert fatigue. If a system is too sensitive, clinicians will eventually start ignoring it, even when it provides a valid warning. Graafsma J et al, *Journal of the American Medical Informatics Association* 2024, emphasize that finding the right balance between sensitivity and specificity is one of the hardest parts of designing a clinical decision support system.
Yes, there are also privacy and security concerns to consider. Moving medical data into an AI platform, even a “transparent” one, carries risks. Hospitals must ensure that their data is protected and that the AI vendors are following all relevant regulations such as HIPAA. Without strong security measures, the trust that these companies are trying so hard to build will vanish instantly.
Conclusion
Undoubtedly, the shift from the “black box” of early generative AI to the “glass box” of evidence-based clinical AI is a necessary step for medicine. Physicians and hospitals are rightly demanding tools that are transparent, verifiable, and grounded in the primary literature. Companies such as OpenEvidence are leading the way by focusing on retrieval rather than just generation, which is exactly what academic medicine needs. If we can solve the problems of trust, integration, and alert fatigue, these tools have the potential to significantly improve patient care and reduce physician burnout. However, we must remain vigilant and treat these systems as clinical aids rather than infallible authorities. If you continue to prioritize evidence over convenience, you can rest assured that your practice will remain at the forefront of medical excellence.
References
- Ouanes K et al. Effectiveness of Artificial Intelligence (AI) in Clinical Decision Support Systems and Care Delivery. Journal of medical systems 2024. doi:10.1007/s10916-024-02098-4 (PMID: 39133332)
- Holbrook A et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012. doi:10.1378/chest.11-2295 (PMID: 22315259)
- Chalasani SH et al. Artificial intelligence in the field of pharmacy practice: A literature review. Exploratory research in clinical and social pharmacy 2023. doi:10.1016/j.rcsop.2023.100346 (PMID: 37885437)
- Sidbury R et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology 2023. doi:10.1016/j.jaad.2022.12.029 (PMID: 36641009)
- El Arab RA et al. The Role of AI in Nursing Education and Practice: Umbrella Review. Journal of medical Internet research 2025. doi:10.2196/69881 (PMID: 40072926)
- Staicu ML et al. Penicillin Allergy Delabeling: A Multidisciplinary Opportunity. The journal of allergy and clinical immunology. In practice 2020. doi:10.1016/j.jaip.2020.04.059 (PMID: 33039010)
- Rony MKK et al. The Role of Artificial Intelligence in Nursing Care: An Umbrella Review. Nursing inquiry 2025. doi:10.1111/nin.70023 (PMID: 40222025)
- Mallineni SK et al. Artificial Intelligence in Dentistry: A Descriptive Review. Bioengineering (Basel, Switzerland) 2024. doi:10.3390/bioengineering11121267 (PMID: 39768085)
- Ramgopal S et al. Artificial intelligence-based clinical decision support in pediatrics. Pediatric research 2023. doi:10.1038/s41390-022-02226-1 (PMID: 35906317)
- Ozmen BB et al. Evidence-based artificial intelligence: Implementing retrieval-augmented generation models to enhance clinical decision support in plastic surgery. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2025. doi:10.1016/j.bjps.2025.03.053 (PMID: 40174259)
- Wang L et al. Artificial intelligence in clinical decision support systems for oncology. International journal of medical sciences 2023. doi:10.7150/ijms.77205 (PMID: 36619220)
- Tun HM et al. Trust in Artificial Intelligence-Based Clinical Decision Support Systems Among Health Care Workers: Systematic Review. Journal of medical Internet research 2025. doi:10.2196/69678 (PMID: 40772775)
- Lin X et al. Artificial Intelligence-Augmented Clinical Decision Support Systems for Pregnancy Care: Systematic Review. Journal of medical Internet research 2024. doi:10.2196/54737 (PMID: 39283665)
- Graafsma J et al. The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: a scoping review. Journal of the American Medical Informatics Association : JAMIA 2024. doi:10.1093/jamia/ocae076 (PMID: 38641410)
- Akay EMZ et al. Artificial Intelligence for Clinical Decision Support in Acute Ischemic Stroke: A Systematic Review. Stroke 2023. doi:10.1161/STROKEAHA.122.041442 (PMID: 37216446)
- https://www.statnews.com/2026/05/20/openevidence-pitches-hospitals-we-are-not-monsters/
Licensed physician and clinical AI specialist. Founder and Editor-in-Chief of ZayedMD, a physician-led medical publication covering clinical AI, neurology, metabolic health, and evidence-based patient guidance.
